RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Christina Sobin to Humans

This is a "connection" page, showing publications Christina Sobin has written about Humans.
Connection Strength

0.414
  1. Del Rio M, Rodriguez C, Alvarado Navarro E, Wekumbura C, Galkaduwa MB, Hettiarachchi GM, Sobin C. Stability of blood lead levels in children with low-level lead absorption. PLoS One. 2023; 18(6):e0287406.
    View in: PubMed
    Score: 0.045
  2. Sobin C, GUTI?RREZ-Vega M, Flores-Montoya G, Rio MD, Alvarez JM, Obeng A, Avila J, Hettiarachchi G. Improving Equitability and Inclusion for Testing and Detection of Lead Poisoning in US Children. Milbank Q. 2023 03; 101(1):48-73.
    View in: PubMed
    Score: 0.044
  3. Alvarez J, Del Rio M, Mayorga T, Dominguez S, Flores-Montoya MG, Sobin C. A Comparison of Child Blood Lead Levels in Urban and Rural Children Ages 5-12?Years Living in the Border Region of El Paso, Texas. Arch Environ Contam Toxicol. 2018 Nov; 75(4):503-511.
    View in: PubMed
    Score: 0.032
  4. Del Rio M, Alvarez J, Mayorga T, Dominguez S, Sobin C. A comparison of arsenic exposure in young children and home water arsenic in two rural West Texas communities. BMC Public Health. 2017 10 27; 17(1):850.
    View in: PubMed
    Score: 0.030
  5. Sobin C. Correspondence: Assessment of learning, memory and attention in developmental neurotoxicology. Neurotoxicol Teratol. 2017 Jan - Feb; 59:76-77.
    View in: PubMed
    Score: 0.029
  6. Flores-Montoya MG, Alvarez JM, Sobin C. Olfactory recognition memory is disrupted in young mice with chronic low-level lead exposure. Toxicol Lett. 2015 Jul 02; 236(1):69-74.
    View in: PubMed
    Score: 0.026
  7. Sobin C, Flores-Montoya MG, Gutierrez M, Parisi N, Schaub T. d-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 (ALAD2) and peptide transporter 2*2 haplotype (hPEPT2*2) differently influence neurobehavior in low-level lead exposed children. Neurotoxicol Teratol. 2015 Jan-Feb; 47:137-45.
    View in: PubMed
    Score: 0.025
  8. Sobin C, Parisi N, Schaub T, de la Riva E. A Bland-Altman comparison of the Lead Care? System and inductively coupled plasma mass spectrometry for detecting low-level lead in child whole blood samples. J Med Toxicol. 2011 Mar; 7(1):24-32.
    View in: PubMed
    Score: 0.019
  9. Sobin C, Parisi N, Schaub T, Gutierrez M, Ortega AX. d-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 and peptide transporter 2*2 haplotype may differentially mediate lead exposure in male children. Arch Environ Contam Toxicol. 2011 Oct; 61(3):521-9.
    View in: PubMed
    Score: 0.019
  10. Sobin C, Gutierrez M, Alterio H. Polymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure. Neurotoxicology. 2009 Nov; 30(6):881-7.
    View in: PubMed
    Score: 0.017
  11. Sobin C, Kiley-Brabeck K, Monk SH, Khuri J, Karayiorgou M. Sex differences in the behavior of children with the 22q11 deletion syndrome. Psychiatry Res. 2009 Mar 31; 166(1):24-34.
    View in: PubMed
    Score: 0.017
  12. Sobin C, Monk SH, Kiley-Brabeck K, Khuri J, Karayiorgou M. Neuromotor deficits in children with the 22q11 deletion syndrome. Mov Disord. 2006 Dec; 21(12):2082-9.
    View in: PubMed
    Score: 0.014
  13. Sobin C, Kiley-Brabeck K, Dale K, Monk SH, Khuri J, Karayiorgou M. Olfactory disorder in children with 22q11 deletion syndrome. Pediatrics. 2006 Sep; 118(3):e697-703.
    View in: PubMed
    Score: 0.014
  14. Kiley-Brabeck K, Sobin C. Social skills and executive function deficits in children with the 22q11 Deletion Syndrome. Appl Neuropsychol. 2006; 13(4):258-68.
    View in: PubMed
    Score: 0.013
  15. Sobin C, Kiley-Brabeck K, Karayiorgou M. Lower prepulse inhibition in children with the 22q11 deletion syndrome. Am J Psychiatry. 2005 Jun; 162(6):1090-9.
    View in: PubMed
    Score: 0.013
  16. Sobin C, Kiley-Brabeck K, Daniels S, Khuri J, Taylor L, Blundell M, Anyane-Yeboa K, Karayiorgou M. Neuropsychological characteristics of children with the 22q11 Deletion Syndrome: a descriptive analysis. Child Neuropsychol. 2005 Feb; 11(1):39-53.
    View in: PubMed
    Score: 0.013
  17. Sobin C, Kiley-Brabeck K, Daniels S, Blundell M, Anyane-Yeboa K, Karayiorgou M. Networks of attention in children with the 22q11 deletion syndrome. Dev Neuropsychol. 2004; 26(2):611-26.
    View in: PubMed
    Score: 0.012
  18. Sobin C, Roos JL, Pretorius H, Lundy LS, Karayiorgou M. A comparison study of early non-psychotic deviant behavior in Afrikaner and US patients with schizophrenia or schizoaffective disorder. Psychiatry Res. 2003 Feb 15; 117(2):113-25.
    View in: PubMed
    Score: 0.011
  19. Carlson LM, Champagne FA, Cory-Slechta DA, Dishaw L, Faustman E, Mundy W, Segal D, Sobin C, Starkey C, Taylor M, Makris SL, Kraft A. Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report. Neurotoxicol Teratol. 2020 Mar - Apr; 78:106865.
    View in: PubMed
    Score: 0.009
  20. Garcia LB, Sobin C, Tomaka J, Santiago I, Palacios R, Walker WS. A Comparison of Water-Related Perceptions and Practices Among West Texas and South New Mexico Colonia Residents Using Hauled-Stored and Private Well Water. J Environ Health. 2016 Sep; 79(2):14-20.
    View in: PubMed
    Score: 0.007
  21. Karayiorgou M, Torrington M, Abecasis GR, Pretorius H, Robertson B, Kaliski S, Lay S, Sobin C, M?ller N, Lundy SL, Blundell ML, Gogos JA, Roos JL. Phenotypic characterization and genealogical tracing in an Afrikaner schizophrenia database. Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 01; 124B(1):20-8.
    View in: PubMed
    Score: 0.003
  22. Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML, Lenane M, Robertson B, Wijsman EM, Rapoport JL, Gogos JA, Karayiorgou M. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A. 2002 Mar 19; 99(6):3717-22.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support